MCK logo

MCK

McKesson CorporationNYSEHealthcare
$884.28+1.37%OpenMarket Cap: $109.14B

As of 2026-04-06

Valuation

View Details

P/E (TTM)

25.15

PEG

0.47

P/B

-83.93

P/S

0.27

EV/EBITDA

17.75

DCF Value

$607.39

FCF Yield

9.3%

Div Yield

0.4%

Margins & Returns

Gross Margin

3.4%

Operating Margin

1.3%

Net Margin

1.1%

ROE

-245.3%

ROA

6.3%

ROIC

24.0%

Financials

View All
PeriodRevenueNet IncomeEPS
Q3 2026$106.16B$1.19B$9.59
Q2 2026$103.15B$1.11B$8.92
Q1 2026$97.83B$784.0M$6.25
Q4 2025$90.82B$1.26B$10.01

Analyst Ratings

View All
BarclaysOverweight
2026-02-18
JP MorganOverweight
2026-02-10
TD CowenBuy
2026-02-05
MizuhoNeutral
2026-02-05
Wells FargoEqual Weight
2026-02-05

Trading Activity

Insider Trades

View All
Lau Micheleofficer: EVP and Chief Legal Officer
SellWed Mar 04
Martinez Mariadirector
SellMon Feb 23
Smith LeAnn Bofficer: EVP & Chief HR Officer
SellWed Feb 18
Lau Micheleofficer: EVP and Chief Legal Officer
SellFri Feb 13
Smith LeAnn Bofficer: EVP & Chief HR Officer
SellThu Feb 12

Congress Trades

View All
Markwayne MullinBuy
Mon Mar 02

Company Info

Sector

Healthcare

Industry

Country

US

Exchange

NYSE

Beta

0.42

McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, International, Medical-Surgical Solutions, and Prescription Technology Solutions (RxTS). The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar, and over-the-counter pharmaceutical drugs and other healthcare-related products. This segment also provides practice management, technology, clinical support, and business solutions to community-based oncology and other specialty practices; and consulting, outsourcing, technological, and other services, as well as sells financial, operational, and clinical solutions to pharmacies. The International segment offers distribution and services to wholesale, institutional, and retail customers in 13 European countries and Canada. The Medical-Surgical Solutions segment provides medical-surgical supply distribution, logistics, and other services to healthcare providers. The RxTS segment serves biopharma and life sciences partners and patients to address medication challenges for patients throughout their journeys; connects pharmacies, providers, payers, and biopharma companies to deliver innovative access and adherence solutions; and provides third-party logistics and wholesale distribution support solutions. McKesson Corporation was founded in 1833 and is headquartered in Irving, Texas.

Peers